In simple terms
Proton therapy is a modern radiation technique that uses charged particles called protons instead of X-rays to destroy cancer cells. When conventional radiation enters the body, it passes right through the tumour and damages healthy tissue behind it. Protons, however, can be programmed to stop moving once they hit the tumour, releasing their cancer-fighting energy precisely where needed and leaving healthy tissues beyond the tumour largely untouched. This precision makes it especially helpful when tumours sit close to vital structures.
Key takeaways
- Uses charged particles that stop inside the tumour, preventing an exit dose.
- The characteristic energy release pattern is known as the Bragg peak.
- Particularly advantageous for childhood cancers and tumours near vital organs.
- Requires specialised particle accelerator facilities like cyclotrons.
Definition
Unlike conventional photon radiation, which penetrates through the target tumour and continues depositing energy along an exit path, protons exhibit a physical phenomenon known as the Bragg peak. Protons are accelerated to high velocities using cyclotrons or synchrotrons and calibrated to travel a predetermined depth into the body.
Upon reaching this precise depth, the protons decelerate rapidly, releasing the majority of their destructive ionising dose within the targeted lesion before coming to a complete stop. Consequently, there is virtually no exit dose of radiation beyond the target area, which substantially lowers unintended radiation exposure to nearby radiosensitive organs and critical structures.
Why it matters
This technology provides immense advantages when treating tumours nestled directly against sensitive, life-sustaining organs like the brainstem, spinal cord, heart, or optic nerves. Reducing collateral tissue damage significantly lowers the risk of both immediate and chronic complications. Furthermore, for paediatric cancer patients, proton therapy drastically curtails the lifetime risk of developmental delays, organ impairment, and radiation-induced secondary malignancies.
Related biomarkers and tests
Suitability is determined through advanced cross-sectional imaging, including four-dimensional computed tomography and magnetic resonance imaging simulation scans. Dosimetric comparison studies, known as comparative planning, are routinely generated to compare proton dose distribution against state-of-the-art photon methods like intensity-modulated radiotherapy.
Related cancers
Proton therapy is heavily utilised in paediatric cancers, where sparing developing normal tissue is imperative. In adult oncology, it is commonly applied in central nervous system tumours, chordomas, chondrosarcomas, base-of-skull neoplasms, ocular melanomas, head and neck cancers, localised prostate cancer, and specific thoracic or liver malignancies.
Related treatments
Proton therapy can serve as a primary curative treatment, as definitive therapy alongside concurrent chemotherapy, or as re-irradiation for tumours that have recurred in previously irradiated anatomical zones. Delivery requires immobilisation casts or masks and sophisticated pencil-beam scanning technology to trace the microscopic contours of the tumour.
Frequently asked questions
How does proton therapy differ from standard radiotherapy?
Standard radiotherapy relies on photon X-ray beams, which deposit radiation along their entire trajectory through the body, including healthy tissue before and after the tumour. Proton therapy uses charged particles that travel to a precise depth, deposit almost all their therapeutic energy directly inside the tumour, and stop completely, eliminating radiation damage to tissues located behind the target area.
Does proton therapy cause any side effects?
Yes. While proton therapy spares healthy organs beyond the tumour, tissues directly adjacent to or in front of the target still receive radiation. Patients may experience skin redness, fatigue, and localised inflammation. However, long-term side effects and collateral damage to neighbouring vital structures are typically far less pronounced than with conventional photon irradiation.
Is proton therapy suitable for all cancer types?
No. Proton therapy is not necessary or practical for every tumour. It delivers the greatest benefit for localised cancers situated near critical anatomical structures—such as the spinal cord or brain—and for paediatric tumours. Widespread metastatic cancers or diffuse disease processes generally derive no added advantage from proton therapy compared to standard therapies.
References
- 1.Proton Therapy to Treat Cancer— National Cancer Institute
- 2.What is Proton Therapy?— American Society of Clinical Oncology (Cancer.Net)
- 3.Particle Therapy in Radiation Oncology— European Society for Medical Oncology
Ask GetOnco AI
Get personalised answers about Proton Therapy — Targeted charged-particle radiation from your AI cancer care coordinator.
- Can you explain Proton Therapy — Targeted charged-particle radiation in simple words?
- What does Proton Therapy — Targeted charged-particle radiation mean for my treatment plan?
- What questions should I ask my oncologist about Proton Therapy — Targeted charged-particle radiation?
- What next steps do you recommend regarding Proton Therapy — Targeted charged-particle radiation?
GetOnco AI provides educational information and never replaces advice from your medical team.
Explore related topics
Related cancer types
Related treatments
More in this section
Glossary terms in this article
Last reviewed August 1, 2026
Medical disclaimer
Educational information only. GetOnco is software, not a medical provider, and does not diagnose disease or recommend treatments. Always discuss your situation with qualified healthcare professionals.